IT IS A COMPARATIVE CLINICAL STUDY TO ACCESS THE EFFECT OF VISHALADI CHURNA AND CHITRAKADI CHURNA IN CHILD HAVING COUGH WITH SPUTUM

A COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF VISHALADI CHURNA AND CHITRAKADI CHURNA IN KAPHAJA KASA IN CHILDREN - Interventional

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/06/034338

Enrollment

Registered

2021-06-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J99- Respiratory disorders in diseasesclassified elsewhere

Interventions

Intervention1: Vishaladi Churna: Oral administration of Vishaladi Churna to each Patient of Kaphaja Kasa 8gms in 4 divided doses per day with Madhu after food for a period of 7 days. Control Intervent

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either gender aged between 06 to 12 years Patients with any of two or more symptoms described in the context of Kaphaja Kasa will be selected Kaphaja Kasa of less than 15 days duration will be selected

Exclusion criteria

Exclusion criteria: Kasa other than Kaphaja type are excluded Kaphaja Kasa as anubandha lakshana and updrava in other systemic diseases Patients below the age group of 06 years and above 12 years

Design outcomes

Primary

Measure	Time frame
Kasa severity Nishteevana Throat Congestion Aruchi Peenasa GauravaTimepoint: At baseline 7th day 10th day	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDr Anu Shree

Alvas Ayurveda Medical College and Hospital Moodbidri

drnarayanpai@gmail.com9902329719

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026